First, the immunostaining of liver biopsy specimens from 40 patients in the Atezo+Bev group revealed a significant positive correlation between serum IL-6 levels and tissue IL-6 expression levels in HCC tumors (Fig. 3a and b). The gene discussed is IL6; the disease is hepatocellular carcinoma.